Background: Blood transfusion is a medical procedure that consists in administering total blood or blood products to requiring patients. In case of transfusion incompatibility, de-immunization occurs in the recipient. Objectives: The aim of this investigation was to determine the post-transfusion frequency of anti-erythrocyte alloimmunisation developed in patients with terminal renal disease. Methods: For this purpose, a cross-sectional descriptive study was conducted for two months at the Yaoundé I University Teaching Hospital. The participants were patients enrolled at the Department of Nephrology and Hemodialysis of this health facility. Alloantibodies were detected and identified by the direct Coombs and red blood cell tests. Data analysis was conducted with tools from the statistical software R-version 4.1.1. Results: Forty-six patients with terminal renal disease were enrolled out of which 41% were women and 59% were men with the overall prevalence of anti-erythrocyte alloimmunisations (anti-rhesus alloimmunisations), at 47.82%. The frequencies of antigens from the Rh system were 89.13%, 67.39%, 78.26%, 32.61% and 30.43% for “D”, “E”, “e”, “C”, and “c” antigens, respectively. Further findings revealed the “O” group as the most common blood group (43.47%) while the rates of alloantibodies were 60% for IgG, 32% for IgM and 8% for IgA. Conclusion: According to these foundings and aiming at reducing anti-erythrocyte alloimmunisation, it appears crucial to limit blood transfusions to their strict indications and to ensure that extended phenotyping is conducted prior to isogroup blood transfusions, otherwise, the best indicated.
Cite this paper
Louokdom, J. S. , Tuono, R. D. M. , Dedjo, K. N. , Tekam, P. Y. M. , Yimta, F. , Tchuessi, P. M. M. , Njopwouo, M. S. and Kwetche, P. R. F. (2023). Anti-Erythrocyte Alloimmunisation in the RH System during Chronic Kidney Disease: Frequency in Patients at the Yaoundé I University Teaching Hospital. Open Access Library Journal, 10, e9932. doi: http://dx.doi.org/10.4236/oalib.1109932.
Baglo, T., Zohoun, A., Agboton, B.L., Vigan, J., Ayaka, P., Anani, L., et al. (2021) Allo-immunisation anti-érythrocytaire chez les polytransfusés au Centre National Hospitalier Universitaire de Cotonou: à propos de 51 cas. Pan African Medical Journal, 38, Article 304.
Roubinet, F. (2003) La distribution des produits sanguins labiles et le risque transfusionnel. Revue Française des Laboratoires, 2003, 53-54.
https://doi.org/10.1016/S0338-9898(03)90091-6
Zidouh, A., Achargui, S., Hajout, K., Abirou, S., Meghfour, F.Z., Monsif, S., et al. (2014) Fréquence de l’alloimmunisation chez les thalassémiques du centre régional de transfusion sanguine de Rabat. Transfusion Clinique et Biologique, 21, 264.
https://doi.org/10.1016/j.tracli.2014.08.069
Pham, B.N., Le Pennec, P.Y. and Rouger, P. (2012) Allo-immunisation anti-érythrocytaire. Transfusion Clinique et Biologique, 19, 321-332.
https://doi.org/10.1016/j.tracli.2012.06.007
Pandey, H., Das, S.S. and Chaudhary, R. (2014) Red Cell Alloimmunization in Transfused Patients: A Silent Epidemic Revisited. Asian Journal of Transfusion Science, 8, 75-77. https://doi.org/10.4103/0973-6247.137433
Frigaa, I., Dekhil, M., Hallaci, S., Zeribi, N., Djennouni, A., Frigaa, H., et al. (2017) Le suivi de l’allo-immunisation transfusionnelle anti-érythrocytaire dans une population de polytransfusés. Transfusion Clinique et Biologique, 24, 351.
https://doi.org/10.1016/j.tracli.2017.06.221
Atouf, O., Brick, C., Benseffaj, N., Ouadghiri, S., El Annaz, H., Essakalli, M. (2013) Recherche des anticorps anti-érythrocytaire en milieu hospitalier: à propos de 2027patients marocains. Immuno-analyse & Biologie Spécialisée, 28, 240-244.
https://doi.org/10.1016/j.immbio.2013.01.004
Elhorri, M. (2020) Allo-immunisation anti-érythrocytaire chez les receveurs: Screening immunologique chez les transfusés de l’Hôpital Militaire Régional Universitaire d’Oran Article original Allo-immunisation anti-érythrocytaire chez les receveurs: Screening immunolo.
Habibi, B. and Lecolier, B. (1983) Inopportunité de la prophylaxie élaborée de l’allo-immunisation transfusionnelle contre les globules rouges dans l’insuffisance rénale chronique. Revue Française de Transfusion et Immuno-hématologie, 26, 267-277. https://doi.org/10.1016/S0338-4535(83)80031-2
Obi, E.I., Pughikumo, C.O. and Oko-Jaja, R.I. (2018) Red Blood Cell Alloimmunization in Multi-Transfused Patients with Chronic Kidney Disease in Port Harcourt, South-South Nigeria. African Health Sciences, 18, 979-987.
https://doi.org/10.4314/ahs.v18i4.18
Mehier, P., Burnier, M. and Pruijm, M. (2017) Inégalité homme-femme face aux maladies rénales chroniques: mythe ou réalité? Revue Médicale Suisse, 13, 473-476.
Yusoff, S.M., Bahar, R., Hassan, M.N., Noor, N.H.M., Ramli, M. and Shafii, N.F. (2020) Prevalence of Red Blood Cell Alloimmunization among Transfused Chronic Kidney Disease Patients in Hospital Universiti Sains Malaysia. Oman Medical Journal, 35, e177. https://doi.org/10.5001/omj.2020.95
Baby, M., Fongoro, S., Cissé, M., Gakou, Y., Bathily, M., Dembélé, A.K., et al. (2010) Fréquence de l’allo-immunisation érythrocytaire chez les malades polytransfusés au centre hospitalo-universitaire du Point G, Bamako, Mali. Transfusion Clinique et Biologique, 17, 218-222. https://doi.org/10.1016/j.tracli.2010.06.026
Achargui, S., Zidouh, A., Abirou, S., Merhfour, F.Z., Monsif, S., Amahrouch, S., et al. (2017) Identification of Alloantibodies and Their Associations: Balance Sheet of 3 Years at the Regional Center of Blood Transfusion in Rabat/Morocco and Difficult in Transfusion Management. Transfusion Clinique et Biologique, 24, 422-430.
https://doi.org/10.1016/j.tracli.2017.04.006
